查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404819

基于透明质酸钠的产品市场规模、份额和趋势分析报告：按类型、应用{药品、化妆品}、地区和细分市场预测，2023-2030

Sodium Hyaluronate-based Products Market Size, Share & Trends Analysis Report By Type (Injectable, Topical), By Application {Pharmaceuticals (Orthopedic, Ophthalmology, Urology), Cosmetics}, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

透明质酸钠产品市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球透明质酸钠产品市场规模将达到177.3亿美元，2023年至2030年复合年增长率为7.7%。

促进市场成长的因素包括老年人口的增加、骨关节炎和白内障的高盛行率、技术进步、意识的提高以及世界上非侵入性美容手术数量的增加。

主要由于世界高龄化人口的增加，抗老化化妆品和逆转衰老征兆的美容护理的需求不断增加。透明质酸钠（NaHA）比透明质酸更易溶解，分子更小，对皮肤的渗透性更好。它越来越多地用于真皮填充剂，将其註入皮肤区域以填充皱纹并恢復更年轻的外观。市面上销售的 FDA 批准的透明质酸钠皮肤填充剂包括 Restylane Defyne、Refyne 和 Restylane。因此，在预测期内，对此类产品的需求预计将成为透明质酸钠产品的强大推动因素。

世界卫生组织预测，到2050年，全球60岁以上人口中估计有15%将患有有症状的骨关节炎。随着高龄化，肥胖和久坐生活方式等其他危险因子的增加预计将进一步加剧这一问题。由于上述因素以及透明质酸钠产品在治疗这些疾病方面的有效性，预计其市场在预测期内将显着增长。

儘管基于透明质酸钠的产品具有显着的优点，但其昂贵的特性可能使某些病患小组无法承受。例如，美国NaHA 注射剂的平均价格为 350 美元至 800 美元。此外，从透明质酸钠真皮填充剂获得的益处是暂时的，可持续长达 18 个月，并且可能需要额外的维持治疗来维持所需的效果，从而导致额外的成本。单相和双相透明质酸产品是昂贵的产品，并非适合所有患者。其高价格主要体现在製造成本高。

此外，SARS-CoV-2的爆发对透明质酸钠市场产生了重大影响。全球外科手术数量的减少和供应链中断减少了全球对透明质酸钠产品的需求。

主要企业正在利用新产品发布和策略合作伙伴关係等多种策略来扩大产品系列併提高竞争力。例如，2020年，工业与Eisai在韩国建立了SI-613（双氯芬酸钠酸共轭透明质酸钠）的销售合作关係。根据该协议，Eisai韩国公司将成为 SI-613 在韩国的独家经销商。

透明质酸钠产品市场报告亮点

  • 到2022年，注射剂领域将占据90%以上的市场份额，因为它具有广泛的用途，包括用于整容手术的真皮填充剂、用于骨关节炎的止痛剂、用于白内障摘除的手术辅助剂以及用于妇科的防沾黏剂手术。占销售额的最大份额。
  • 2022 年，製药业占最大收益占有率，超过 60%，由于各种製药应用的高使用率，预计在预测期内将以 7.9% 的最快复合年增长率增长。
  • 北美地区主导市场，2022 年收益占有率最大，超过 35%。这是由于与其他地区相比，医疗保健支出更高，白内障和皮肤填充剂手术的数量也更多。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章微针给药系统市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 透明质酸钠产品市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 透明质酸钠产品：类型估计与趋势分析

  • 透明质酸钠产品市场：重点
  • 透明质酸钠产品市场：2022 年和 2030 年趋势和市场占有率分析
  • 局部的
    • 2018-2030 年局部市场估计与预测
  • 可注射的
    • 2018-2030 年註射药品市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第五章 透明质酸钠产品：估计使用量与趋势分析

  • 透明质酸钠产品市场：重点
  • 透明质酸钠产品市场：2022 年和 2030 年趋势和市场占有率分析
  • 药品
    • 2018-2030 年医药市场估计与预测
  • 化妆品
    • 2018-2030 年化妆品市场预测

第六章 透明质酸钠产品：区域估计与趋势分析

  • 区域展望
  • 基于透明质酸钠的产品：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Allergan, Inc.(a part of AbbVie, Inc.)
    • Galderma SA
    • Bohus BioTech AB
    • LG Chem Ltd.
    • Syner-Med (Pharmaceutical Products) Ltd.
    • Anika Therpeutics Inc.
    • Cadila Pharmaceuticals Ltd.
    • Ferring Pharmaceuticals BV
    • Fidia Farmaceutici SpA
Product Code: GVR-4-68038-345-4

Sodium Hyaluronate-based Products Market Growth & Trends:

The global sodium hyaluronate-based products market size is expected to reach USD 17.73 billion by 2030, registering a CAGR of 7.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to factors such as the increasing geriatric population, a high prevalence of osteoarthritis and cataracts, technological advancements, rising awareness, and a growing number of non-invasive aesthetic procedures globally.

The demand for antiaging cosmetics and aesthetic treatments, which help people in reversing their aging signs, is increasing, mainly due to a global increase in the aging population. Sodium hyaluronate (NaHA) is more soluble than hyaluronic acid, along with having smaller molecules and greater skin penetration. It is increasingly being used in dermal fillers that are injected into areas of the skin to fill out wrinkles and help restore a more youthful appearance. Some of the FDA-approved sodium hyaluronate dermal fillers available in the market are Restylane Defyne, Refyne, and Restylane. Thus, it is anticipated that the need for such products will act as a high-impact rendering driver for sodium hyaluronate-based products over the forecast period.

The WHO predicts that by 2050, an estimated 15% of the world's population above the age of 60 years will suffer from symptomatic osteoarthritis. Along with the aging population, an increase in other risk factors such as obesity and a sedentary lifestyle is expected to further exacerbate the problem. Due to the aforementioned factors and the effectiveness of sodium hyaluronate products in treating these conditions, its market is expected to grow significantly over the forecast period.

Although sodium hyaluronate-based products offer major benefits, due to their expensive nature, they can be out of reach for certain patient groups. For instance, the average price of NaHA injections in the U.S. ranges from USD 350 to USD 800. Moreover, benefits derived from sodium hyaluronate dermal fillers are temporary, lasting up to 18 months and requiring further upkeep treatments to maintain the desired effect, leading to additional expenses. Single-phase products and duplex products of hyaluronic acid are premium-priced products, and thus, they are not accessible to all patients. Their high price primarily reflects high manufacturing costs.

Moreover, the SARS-CoV-2 pandemic has substantially impacted the sodium hyaluronate market. A decrease in the number of surgical procedures worldwide and disruptions in the supply chain have reduced the demand for sodium hyaluronate-based products worldwide.

Key players are leveraging multiple strategies such as new product launches and strategic partnerships to expand their product portfolio, and thereby, have a more competitive range of offerings. For instance, in 2020, Seikagaku Corporation and Eisai Co., Ltd. formed a marketing alliance for SI-613 (diclofenac-conjugated sodium hyaluronate) in South Korea. Based on this agreement, Eisai Korea, Inc. will be the exclusive distributor of SI-613 in South Korea.

Sodium Hyaluronate-based Products Market Report Highlights:

  • The injectable segment accounted for the largest revenue share of over 90% in 2022 owing to a wide range of applications, such as dermal fillers in cosmetic procedures, pain relief in osteoarthritis, surgical aids in cataract extractions, and anti-adhesives in gynecological operations
  • The pharmaceutical segment held the largest revenue share of over 60% in 2022 and is anticipated to grow at the fastest CAGR of 7.9% over the forecast period owing to the high usage in a variety of pharmaceutical applications
  • North America dominated the market and accounted for the largest revenue share of over 35% in 2022 due to the higher healthcare expenditure and a greater number of cataract and dermal filler procedures as compared to other regions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Sodium Hyaluronate - Based Products Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Sodium Hyaluronate-Based Products: Type Estimates & Trend Analysis

  • 4.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 4.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical
    • 4.3.1. Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4. Injectable
    • 4.4.1. Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Sodium Hyaluronate-Based Products: Applications Estimates & Trend Analysis

  • 5.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 5.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceuticals
    • 5.3.1. Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.1. Ophthalmic
      • 5.3.1.1.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.2. Orthopedic
      • 5.3.1.2.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.3. Urology
      • 5.3.1.3.1. Urology market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Cosmetics
    • 5.4.1. Cosmetics market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Sodium Hyaluronate-Based Products: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Sodium Hyaluronate-Based Products: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allergan, Inc.(a part of AbbVie, Inc.)
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Galderma S.A.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bohus BioTech AB
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. LG Chem Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Syner-Med (Pharmaceutical Products) Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Anika Therpeutics Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Cadila Pharmaceuticals Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Ferring Pharmaceuticals B.V.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Fidia Farmaceutici S.p.A.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 6 Canada sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 11 Germany sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 14 UK sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 15 France sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 16 France sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 17 Italy sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 18 Italy sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Spain sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 20 Spain sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 21 Sweden sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 22 Sweden sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 23 Norway sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 24 Norway sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 30 China sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 31 China sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 32 Japan sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 33 Japan sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 34 India sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 35 India sodium hyaluronate-based products market, by application, (USD Million) 2018 - 2030
  • Table 36 Australia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 37 Australia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 39 Thailand sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 41 South Korea sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 43 Latin America sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 45 Brazil sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Mexico sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 48 Mexico sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 49 Argentina sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 50 Argentina sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 54 South Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 58 UAE sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 59 UAE sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 60 Kuwait sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle drug delivery systems: Market outlook
  • Fig. 9 Microneedle drug delivery systems: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Sodium hyaluronate-based products market driver impact
  • Fig. 15 Sodium hyaluronate-based products market restraint impact
  • Fig. 16 Sodium hyaluronate-based products market strategic initiatives analysis
  • Fig. 17 Sodium hyaluronate-based products market: Type movement analysis
  • Fig. 18 Sodium hyaluronate-based products market: Type outlook and key takeaways
  • Fig. 19 Topical market estimates and forecasts, 2018 - 2030
  • Fig. 20 Injectable market estimates and forecasts, 2018 - 2030
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030
  • Fig. 22 Sodium hyaluronate-based products market: Application movement analysis
  • Fig. 23 Sodium hyaluronate-based products market: Application outlook and key takeaways
  • Fig. 24 Pharmaceutical market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cosmetics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global sodium hyaluronate-based products market: Regional movement analysis
  • Fig. 27 Global sodium hyaluronate-based products market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030